Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Hematologic agents

Argatroban (Acova) Bivalirudin (Angiomax) Dalteparin (Fragmin) [Pg.49]

Abciximab (ReoPro) Aspirin (Bayer, Ecotrin, St. Joseph s) Clopiclogrel (Plavix) [Pg.49]

Alteplase, Recombinant [tPA] (Activase) Aminocaproic Acid (Amicar) [Pg.49]

Aprotinin (Trasylol) Dextran 40 (Gentran 40, Rheomacrodex) Reteplase (Retavase) [Pg.49]

Api otinin (Trasylol) Dexti an 40 (Genti an 40, Rlieomaci odex) Reteplase (Retavase) [Pg.49]

Filgrastim [G-CSF] (Neupogen) Oprelvekin (Neumega) Pegfilgrasdm (Neulasta) [Pg.49]

Hetastai ch (Hespan) Plasma Pi otein Fraction (Plasmanate) [Pg.49]

Pi otamine generic Tinzaparin (Innohep) Wai farin (Coumadin) [Pg.49]

Eptifibadde (Integrilin) Reteplase (Retavase) Ticlopidine (Tlclid) Tii ofiban (Aggrastat) [Pg.49]

Lockwood SF, Jackson HL, and Gross GJ. 2006a. Retrometabolic syntheses of astaxanthin (3,3 -dihydroxy-P,P-carotene-4,4 -dione) conjugates A novel approach to oral and parenteral cardioprotection. Cardiovascular Hematological Agents 4 335-349. [Pg.56]

Hematological agents In clinical trials in patients undergoing PTCA/PCI, coadministration of bivalirudin with heparin, warfarin, thrombolytics, or GPIIb/llla inhibitors was associated with increased risks of major bleeding events compared with patients not receiving these concomitant medications. There is no experience with coadministration of bivalirudin and plasma expanders such as dextran. [Pg.162]

Mechanism of Action A hematologic agent that reduces platelet production and prevents platelet shape changes caused by platelet aggregating agents. Therapeutic Effect Inhibits platelet aggregation. [Pg.80]

CNS (central nervous system) Hematological agents Vitamins... [Pg.367]

Ceo, L. B. 2005. Natriuretic peptide family New aspects. Current Medical Chemistry Cardiovascular Hematology Agents 3 87-98. [Pg.139]

Silveira, P. R, J. Gil, L. Casis, and J. Irazusta. 2004. Peptide metabolism and the control of body fluid homeostasis. Current Medicinal Chemistry and Cardiovascular Hematology Agents 2 219-238. [Pg.139]

Microarray Applications in Occlusive Vascular Disease. Cardiovascular Hematological Agents in Medicinal Chemistry, Vol.9, pp. 84-94. [Pg.223]

See other pages where Hematologic agents is mentioned: [Pg.5]    [Pg.50]    [Pg.50]    [Pg.438]    [Pg.3]    [Pg.49]    [Pg.49]    [Pg.3]    [Pg.49]    [Pg.49]   
See also in sourсe #XX -- [ Pg.3 , Pg.49 ]

See also in sourсe #XX -- [ Pg.3 , Pg.49 ]

See also in sourсe #XX -- [ Pg.3 , Pg.49 ]



SEARCH



© 2024 chempedia.info